Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IT'S PREMATURE!

Re: Borredo...You're correct

posted on Jan 09, 2009 03:31AM

Per your post...

The consideration of a reverse split smacks of desperation. IMO

It was a desparate move....for POPMAIL....for us it will be a smart, calculated move to get off the BB when the price has risen (hopefullly to over $1/share) our revenues are increasing, the reexams are behind us and our M&A projects are starting to take hold and produce earnings.

32 stocks this year--10 of which are tech companies--have gone through reverse splits. However, 22 percent of those stocks have slipped back below $1 and into penny-stock status,

Wow...7 out of 32 fell back...let's see that means 25 out 32 didn't...and some of those might have been for the same reason as POPMAIL but their financials were probably better.

I guess its how one tells the story...7 out 32 didnt work...BUT 25 out of 32 did...that's 78% that were successful in their RS..for whatever reason...in a year so we will one of those in the 78% category IMO.



Share
New Message
Please login to post a reply